people in the UK are estimated to live with inflammatory bowel disease including Crohn’s disease.
people with Crohn’s disease in the UK are diagnosed before the age of 20.
Chronic abdominal pain related to Crohn’s disease is a recognised reason patients access specialist long-term care in the UK.
If these symptoms sound familiar and persist despite usual treatments, you can check your eligibility for medical cannabis treatment in minutes through our simple online assessment.
Crohn’s disease is commonly treated with anti-inflammatory medicines, corticosteroids, immunosuppressants, and biologic therapies. Nutritional support and dietary adjustments are also used to reduce inflammation and maintain remission under NHS-style guidance.
For individuals whose inflammation and abdominal pain remain difficult to manage through standard therapies, medical cannabis may offer a regulated alternative pathway under specialist supervision. At LeafEase, patients access a structured, clinically guided treatment process designed to assess suitability and provide safe, ongoing symptom management.
Crohn’s disease develops when the immune system triggers ongoing inflammation in the digestive tract. The exact cause of Crohn’s disease is not fully understood, but research suggests it results from a combination of immune system activity, genetic factors, and environmental triggers affecting the digestive tract.
Find out if you may be eligible for Crohn’s disease medical cannabis treatment here.
Medical cannabis helps Crohn’s disease by interacting with the body’s endocannabinoid system (ECS), which influences inflammation, pain signalling, and gut function.
Cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) can help support regulation of inflammatory responses, reduce abdominal discomfort, and support appetite. In the UK, it is prescribed and monitored by specialist clinicians to ensure safety and effectiveness.
Studies on Medical Cannabis as an Alternative Treatment for Crohn’s Diseases
Ref: https://www.cochrane.org/evidence/CD012853_cannabis-and-cannabis-oil-treatment-crohns-disease
At LeafEase, treatment is delivered under specialist supervision, ensuring every patient is safely assessed and supported throughout their care. Our personalised approach helps you explore medical cannabis as a regulated, clinically guided option for long-term pain relief.
Medical cannabis is used within a regulated clinical framework, and side effects can vary depending on dosage and product type.
Most side effects are mild and often settle once the dosage is optimised, with patients receiving ongoing clinical follow up.
Find out whether medical cannabis may be a suitable treatment option for Crohn’s disease
Simply submit your questions, and we’ll do our best to address them promptly and thoroughly. Your health is our priority, and we’re here to support you every step of the way.
Yes, it can be prescribed by specialist clinicians under regulated medical care when conventional treatments have not provided adequate symptom control.
It works through the endocannabinoid system to help regulate inflammation, abdominal pain, and appetite.
Onset varies by product and individual, but some people notice improvements in pain or sleep within hours of dosing, while inflammation-related effects may take longer.
Yes, cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) may help reduce pain intensity in some patients.
At LeafEase, eligibility is determined through a specialist clinical assessment that reviews your symptoms, medical history, and previous treatments to evaluate whether regulated medical cannabis treatment may be appropriate for managing restless leg syndrome.
